Pemphigus Foliaceus
📧 Sign up to get email alerts when something new happens for Pemphigus Foliaceus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus) [Phase 3]
A Phase 3 trial evaluating the long-term safety and efficacy of subcutaneous efgartigimod PH20 SC in adults with pemphigus vulgaris or pemph…
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: A Study to Assess the Efficacy and Safety of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus) [Phase 3]
A Phase 3 study evaluating subcutaneous efgartigimod PH20 SC in adults with pemphigus vulgaris or foliaceus has completed and posted results…
-
CLINICAL_TRIALS trial_result · 2021-11-22Clinical Trial Update: Polyclonal Regulatory T Cells (PolyTregs) for Pemphigus [Phase 1]
Phase 1 trial update for polyclonal regulatory T cells (PolyTregs) in pemphigus shows terminated study with posted results.
-
CLINICAL_TRIALS trial_result · 2020-12-14Clinical Trial Update: A Study to Evaluate the Safety, PD, PK and Efficacy of ARGX-113 in Patients With Pemphigus [Phase 2]
Phase 2 trial assessing safety, pharmacodynamics, pharmacokinetics, and efficacy of ARGX-113 in patients with pemphigus vulgaris and pemphig…
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: A Safety and Dose-Finding Study of SYNT001 in Subjects With Pemphigus (Vulgaris or Foliaceus) [Phase 1, Phase 2]
A safety and dose-finding study of SYNT001 in pemphigus (vulgaris or foliaceus) was conducted in Phase 1/2 and subsequently terminated; resu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.